Back to Search
Start Over
LATEST COMPANY NEWS
- Source :
- United Kingdom Pharmaceuticals. December 12, 2023
- Publication Year :
- 2023
-
Abstract
- #(1) PMLiVE - AstraZeneca/Merck's Lynparza combination recommended by NICE for advanced ovarian cancer - 8/12/2023 AstraZeneca (AZ) and Merck's, known as MSD outside the US and Canada, Lynparza (olaparib) has [...]
- Subjects :
- United States. Food and Drug Administration -- International economic relations
Merck & Company Inc. -- International economic relations
Pfizer Inc. -- International economic relations
Roche Holding (UK) Ltd. -- International economic relations
AstraZeneca PLC -- International economic relations
London Stock Exchange PLC -- International economic relations
Antineoplastic agents -- Health aspects
Endometrial cancer -- Care and treatment
Cancer -- Care and treatment
Ovarian cancer -- Care and treatment
Securities industry -- International economic relations
Pharmaceutical industry -- International economic relations
Antimitotic agents -- Health aspects
Securities industry
Business, international
Kadcyla (Medication) -- Health aspects
Lynparza (Medication) -- Health aspects
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- United Kingdom Pharmaceuticals
- Publication Type :
- News
- Accession number :
- edsgcl.776206896